Hangzhou TianMuShan Pharmaceutical Enterprise Co.,Ltd

SHSE:600671 Stock Report

Market Cap: CN¥1.1b

Hangzhou TianMuShan Pharmaceutical EnterpriseLtd Management

Management criteria checks 1/4

We currently do not have sufficient information about the CEO.

Key information

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenureno data
CEO ownershipn/a
Management average tenureno data
Board average tenure3.3yrs

Recent management updates

Recent updates

What Hangzhou TianMuShan Pharmaceutical Enterprise Co.,Ltd's (SHSE:600671) 27% Share Price Gain Is Not Telling You

Oct 25
What Hangzhou TianMuShan Pharmaceutical Enterprise Co.,Ltd's (SHSE:600671) 27% Share Price Gain Is Not Telling You

Hangzhou TianMuShan Pharmaceutical Enterprise Co.,Ltd (SHSE:600671) Investors Are Less Pessimistic Than Expected

Jul 18
Hangzhou TianMuShan Pharmaceutical Enterprise Co.,Ltd (SHSE:600671) Investors Are Less Pessimistic Than Expected

CEO

Hangzhou TianMuShan Pharmaceutical EnterpriseLtd has no CEO, or we have no data on them.

Board Members

NamePositionTenureCompensationOwnership
Guojun Dang
Vice Chairman & Board Secretary3.5yrsCN¥110.10kno data
Yang Pei
Independent Director3.5yrsCN¥100.00kno data
Hua Cheng
Employee Supervisor3yrsno datano data
Lu Wang
Supervisor2.5yrsno datano data

3.3yrs

Average Tenure

38.5yo

Average Age

Experienced Board: 600671's board of directors are considered experienced (3.3 years average tenure).